Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “METASTATIC BREAST CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03184090
What this trial is testing

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

Who this might be right for
Metastatic Breast Cancer
MedSIR 33
Testing effectiveness (Phase 2)Study completedNCT00010010
What this trial is testing

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Not applicableEnrolling By InvitationNCT06821490
What this trial is testing

Validation of TAD in HER-2 with More Than 2 Lymph Nodes

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeHER2 Positive Breast Carcinoma
Fundación para la Investigación del Hospital Clínico de Valencia 21
Testing effectiveness (Phase 2)UnknownNCT05461690
What this trial is testing

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

Who this might be right for
Homologous Recombination DeficiencyTriple Negative Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03241810
What this trial is testing

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Elevation Oncology 22
Not applicableUnknownNCT05826197
What this trial is testing

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

Who this might be right for
Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07766018
What this trial is testing

Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Stemline Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Looking for participantsNCT07394218
What this trial is testing

CtDNA-guided Treatment Decision-making

Who this might be right for
Metastatic Breast Cancer ( HER2 Negative)ctDNA
Fudan University 122
Not applicableUnknownNCT04929197
What this trial is testing

Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing

Who this might be right for
Breast NeoplasmsBreast CancerLeft Sided Breast Cancer
Taipei Medical University Hospital 50
Testing effectiveness (Phase 2)UnknownNCT06458413
What this trial is testing

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Who this might be right for
Breast Cancer Recurrent
Min Yan, MD 40
Testing effectiveness (Phase 2)Study completedNCT01885013
What this trial is testing

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 126
Testing effectiveness (Phase 2)UnknownNCT05792410
What this trial is testing

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Who this might be right for
HER2 Low Advanced or Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT00017394
What this trial is testing

Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 56
Not applicableLooking for participantsNCT06807502
What this trial is testing

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

Who this might be right for
Breast Cancer, MetastaticBreast Cancer InvasiveBreast Cancer Early Stage Breast Cancer (Stage 1-3)
ScreenCell 93
Not applicableUnknownNCT05831553
What this trial is testing

TIP in Patients Affected by Metastatic TNBC

Who this might be right for
Metastatic Triple-negative Breast Cancer
Fondazione per la Medicina Personalizzata 100
Testing effectiveness (Phase 2)Ended earlyNCT04243837
What this trial is testing

LYT-100 in Patients With BCRL

Who this might be right for
Breast Cancer Related LymphoedemaLymphoedema
PureTech 50
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Not applicableStudy completedNCT03252145
What this trial is testing

Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device

Who this might be right for
Lymphedema, SecondaryLymphedema of Upper Limb
University of California, San Francisco 28
Not applicableStudy completedNCT03975621
What this trial is testing

Nurse AMIE: Addressing Metastatic Individuals Everyday

Who this might be right for
Metastatic Breast Cancer
Milton S. Hershey Medical Center 21
Next Page